Market Tracker

07/29 5:16pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.34
Delayed Data
As of Jul 29
 -0.0074 / -0.32%
Today’s Change
1.63
Today|||52-Week Range
15.01
+15.72%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close2.35
Today’s open2.28
Day’s range2.28 - 2.34
Volume15,891
Average volume (3 months)36,083
Market cap$21.0M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+81.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZSANZosano Pharma Corp-0.07-3.85%
APRIApricus Biosciences ...-0.01-3.86%
IMNPImmune Pharmaceutica...+0.01+2.56%
JAGXJaguar Animal Health...+0.02+1.16%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts